KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd (MGRC) posted a net profit of RM1.01mil in the second quarter ended Dec 31, 2021 (2Q22) compared with a net loss of RM1.55mil in the same period a year prior.
The improved performance was due to its successful penetration into the distribution of immunotherapy and cell therapies, which contributed to a higher margin.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!